Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125263573 | 12526357 | 3 | F | 201509 | 20160722 | 20160705 | 20160801 | PER | US-PFIZER INC-2016326876 | PFIZER | 59.00 | YR | F | Y | 51.25000 | KG | 20160801 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125263573 | 12526357 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, 1X/DAY | M51569 | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QD | |||||
| 125263573 | 12526357 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, 1X/DAY | N40177 | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QD | |||||
| 125263573 | 12526357 | 3 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, ALTERNATE DAY | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QOD | ||||||
| 125263573 | 12526357 | 4 | C | ATIVAN | LORAZEPAM | 1 | Oral | 1 TABLET (^50 MG^), 1X/DAY AT NIGHT | 0 | 1 | DF | TABLET | QD | ||||||
| 125263573 | 12526357 | 5 | C | ATIVAN | LORAZEPAM | 1 | 0 | TABLET | |||||||||||
| 125263573 | 12526357 | 6 | C | ATIVAN | LORAZEPAM | 1 | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125263573 | 12526357 | 1 | Depression |
| 125263573 | 12526357 | 2 | Anxiety |
| 125263573 | 12526357 | 3 | Crying |
| 125263573 | 12526357 | 4 | Sleep disorder |
| 125263573 | 12526357 | 5 | Insomnia |
| 125263573 | 12526357 | 6 | Anxiety disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125263573 | 12526357 | Abnormal behaviour | |
| 125263573 | 12526357 | Anxiety | |
| 125263573 | 12526357 | Crying | |
| 125263573 | 12526357 | Depression | |
| 125263573 | 12526357 | Intentional product misuse | |
| 125263573 | 12526357 | Thinking abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125263573 | 12526357 | 1 | 200607 | 0 | ||
| 125263573 | 12526357 | 3 | 20160401 | 0 | ||
| 125263573 | 12526357 | 4 | 200607 | 0 |